Integer (NYSE:ITGR) Insider Sells $1,188,230.40 in Stock

Integer Holdings Corporation (NYSE:ITGR) insider Andrew Senn sold 9,408 shares of the business’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $126.30, for a total transaction of $1,188,230.40. Following the transaction, the insider owned 5,405 shares in the company, valued at $682,651.50. This represents a 63.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Integer Stock Up 0.0%

ITGR stock opened at $126.06 on Friday. Integer Holdings Corporation has a 1-year low of $62.00 and a 1-year high of $126.79. The business’s 50 day simple moving average is $114.21 and its 200 day simple moving average is $97.28. The company has a current ratio of 3.73, a quick ratio of 2.41 and a debt-to-equity ratio of 0.75. The firm has a market capitalization of $4.28 billion, a PE ratio of 34.44, a PEG ratio of 2.40 and a beta of 0.62.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.38 by $0.22. The company had revenue of $464.11 million for the quarter, compared to analyst estimates of $451.07 million. Integer had a net margin of 6.97% and a return on equity of 12.79%. The company’s revenue was down 2.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.55 earnings per share. As a group, research analysts anticipate that Integer Holdings Corporation will post 6.09 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on ITGR shares. Freedom Capital downgraded shares of Integer from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 4th. Weiss Ratings reiterated a “hold (c)” rating on shares of Integer in a research note on Thursday, June 18th. Raymond James Financial downgraded Integer from a “moderate buy” rating to a “hold” rating in a research note on Monday, August 3rd. Benchmark lowered Integer from a “buy” rating to a “hold” rating in a report on Thursday, August 13th. Finally, HC Wainwright reiterated a “buy” rating on shares of Integer in a research report on Friday, July 24th. One investment analyst has rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $109.86.

Institutional Trading of Integer

Large investors have recently bought and sold shares of the business. Barrow Hanley Mewhinney & Strauss LLC acquired a new position in Integer during the second quarter worth about $29,000. EverSource Wealth Advisors LLC grew its holdings in shares of Integer by 48.1% during the 1st quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 117 shares during the last quarter. Harbor Investment Advisory LLC bought a new stake in shares of Integer during the 2nd quarter valued at approximately $42,000. TD Private Client Wealth LLC increased its position in Integer by 1,037.5% during the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock worth $36,000 after purchasing an additional 415 shares in the last quarter. Finally, Parkside Financial Bank & Trust lifted its stake in Integer by 135.5% in the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 267 shares during the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.

About Integer

Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.

Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.